跳至主要内容
临床试验/NCT04110418
NCT04110418Unknown2 期

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

Ain Shams University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2019年2月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
36
试验地点
1
主要终点
to assess the efficancy of each intervention in improving hemodymaic status: time taken to reach adequate mean blood pressure

研究概览

简要总结

A randomized, prospective study comparing methylene blue versus terlipressin in treatment of catecholamines resistant shock in preterm neonate

详细描述

The study will be an un-blinded, Phase 2, randomized, 1:1, prospective trial comparing methylene blue versus terlipressin in treatment of preterm neonate with catecholamines resistant septic shock the outcome as regard elevation of mean arterial blood pressure will be measured within 72 hours

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • diagnosis of Septic shock according to clinical sepsis score of Tollner and Hematologic Scoring System of Rodwell
  • Refractory septic shock defined as hypotension although adequate fluid resuscitate and high dose vasopressor(NE >0.5 mcg/kg/min)
  • consent form

排除标准

  • known case of G6pd deficiency
  • Hx of drug allergy MB, NE, terlipressin
  • Patients with severely impaired renal function.
  • History of maternal drug intake of selective serotonin reuptake inhibitors,and Serotonin-Norepinephrine Reuptake Inhibitors

研究组 & 干预措施

Methylene Blue group (Group MB)

Active Comparator

Methylene Blue is supplied in 1 ml or 10 mL single-dose ampules. Each 1 mL ampule contains 10 mg of methylene blue as a clear dark blue solution

  • Any unused product or waste material should be disposed of in accordance with local practice,
  • For administration to be diluted before use in a solution of 50 mL 5% Dextrose in Water (D5W) in order to avoid local pain, particularly in the paediatric population. Use the diluted solution immediately after preparation.
  • Do not mix with sodium chloride 9 mg/mL (0.9%) solution for injection, because it has been demonstrated that chloride reduces the solubility of methylene blue.

干预措施: Methylene Blue (Drug)

Terlipressin Group (Group TP )

Placebo Comparator

The active substance is terlipressin acetate. Each ampoule contains

1 mg of terlipressin acetate in 8.5 ml solution for injection. This is equivalent to 0.12 mg terlipressin acetate per ml.

  • The powder is to be dissolved in the enclosed solvent and slowly administered intravenously. Further dilution up to 10 ml with sterile isotonic sodium chloride solution is possible.
  • Store in a refrigerator at 2-8˚C.
  • Keep the ampoules in the outer carton in order to protect from light

干预措施: Methylene Blue (Drug)

结局指标

主要结局

to assess the efficancy of each intervention in improving hemodymaic status: time taken to reach adequate mean blood pressure

时间窗: 24hours

The time taken to reach adequate mean blood pressure Reduction in the dosage of the standard inotropic support

次要结局

  • to assess the effect of intervention on survival(4 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rabab Gameel Abd EL hamid allam

Assistant lecturer

Ain Shams University

研究点 (1)

Loading locations...

相似试验